Relapsed/refractory multiple myeloma updates at ASH 2020: How can we integrate the latest data into patient management?
After participating in this broadcast you should be able to:
- Discuss the potential impact of data presented at the American Society of Hematology (ASH) 2020 congress on the management of patients with relapsed/refractory multiple myeloma
- Mohamad Mohty (France)
- Meletios Dimopoulos (Greece)
- Michel Delforge (Belgium)